Physician profile
Mary Qiu
NPI 1972917292
$98,941.30
in general payments reported to CMS, 2019-2025
13 companies · $65K in 2025
The $65K reported for 2025 was more than what 98% of Glaucoma Specialist providers received nationally (typical 2025 total: $608).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $185 · 2022: $562 · 2023: $1,011 · 2024: $32K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $53K · Travel and Lodging: $31K · Food and Beverage: $8,372 · Honoraria: $3,400 · Education: $2,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $53,424.43 |
| Travel and Lodging | $30,729.43 |
| Food and Beverage | $8,371.93 |
| Honoraria | $3,400.00 |
| Education | $2,035.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nova Eye, INC. | $82,682.66 | 2024-2025 | |
| New World Medical,INC. | $7,259.07 | 2019-2025 | Ahmed Glaucoma Valve, Streamline, Clearpath |
| Abbvie INC. | $5,168.25 | 2023-2025 | |
| Sight Sciences, INC. | $985.48 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| Alcon Vision LLC | $801.31 | 2019-2025 | Hydrus Microstent, Clareon, Unity |
| W. L. Gore & Associates, INC. | $782.72 | 2025 | Product In Development |
| Glaukos Corporation | $377.77 | 2024-2025 | Idosetr, Idose |
| Microsurgical Technology, INC. | $259.62 | 2024 | |
| Carl Zeiss Meditec, INC. | $191.25 | 2025 | |
| Tarsus Pharmaceuticals, INC. | $154.88 | 2025 | Xdemvy |
| Aerie Pharmaceuticals, INC. | $138.59 | 2020 | |
| Sun Pharmaceutical Industries INC. | $113.80 | 2022 | |
| Allergan, INC. | $25.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Qiu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.